Activation of podocyte-specific MC5R signaling by melanocortin therapy protects against THSD7A-associated membranous nephropathy. Translation [Internet]. 2025 Jun. 30 [cited 2026 Jul. 27];13(S3). Available from: https://dev.openjournals.utoledo.edu/index.php/translation/article/view/1354